ReP USP - Resultado da busca

Artigo de periodico
Sex-specific regulation of miR-22 and ERα in white adipose tissue of obese dam's female offspring impairs the early postnatal development of functional beige adipocytes in mice (2024)
Sousa, Érica de; Bolin, Anaysa Paola ; Oliveira, Nayara Preste de; Real, Caroline Cristiano ; Hu, Xiaoyun ; Huang, Zhan-Peng ; Wang, Da Zhi ; Rodrigues, Alice Cristina
Source: Biochimica et Biophysica Acta. Molecular Basis of Disease. Unidades: ICB, FCF
Subjects: FARMACOLOGIA, ONTOGENIA, ÁCIDOS GRAXOS, OXIDAÇÃO, OBESIDADE, ADIPOSIDADE, TECIDO ADIPOSO, ESTRÓGENOS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Érica de et al. Sex-specific regulation of miR-22 and ERα in white adipose tissue of obese dam's female offspring impairs the early postnatal development of functional beige adipocytes in mice. Biochimica et Biophysica Acta. Molecular Basis of Disease, v. 1870, n. 4, p. 15 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bbadis.2024.167057. Acesso em: 01 jun. 2024.
APA
Sousa, É. de, Bolin, A. P., Oliveira, N. P. de, Real, C. C., Hu, X., Huang, Z. -P., et al. (2024). Sex-specific regulation of miR-22 and ERα in white adipose tissue of obese dam's female offspring impairs the early postnatal development of functional beige adipocytes in mice. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1870( 4), 15 . doi:10.1016/j.bbadis.2024.167057
NLM
Sousa É de, Bolin AP, Oliveira NP de, Real CC, Hu X, Huang Z-P, Wang DZ, Rodrigues AC. Sex-specific regulation of miR-22 and ERα in white adipose tissue of obese dam's female offspring impairs the early postnatal development of functional beige adipocytes in mice [Internet]. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2024 ; 1870( 4): 15 .[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.bbadis.2024.167057
Vancouver
Sousa É de, Bolin AP, Oliveira NP de, Real CC, Hu X, Huang Z-P, Wang DZ, Rodrigues AC. Sex-specific regulation of miR-22 and ERα in white adipose tissue of obese dam's female offspring impairs the early postnatal development of functional beige adipocytes in mice [Internet]. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2024 ; 1870( 4): 15 .[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.bbadis.2024.167057
Artigo de periodico
Vascular dysfunction programmed in male rats by topiramate during peripubertal period (2024)
Moura, Kawane Fabricio ; Silva, Deborah Gomes da ; Vidigal, Camila Borecki ; Silva, Gabriel Smolak Sobieski e ; Pinto, Ingrid Caroline; Simão, André Name Colado ; Marques, Bruno Vinicius Duarte ; Andrade, Fábio Goulart de ; Casagrande, Rúbia ; Gerardin, Daniela Cristina Ceccatto ; Franco, Maria do Carmo Pinho ; Ceravolo, Graziela Scalianti ; Akamine, Eliana Hiromi
Source: Life Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, ACETILCOLINA, ANIMAIS, ANTIOXIDANTES, AORTA TORÁCICA, ENDOTÉLIO VASCULAR, ÓXIDO NÍTRICO, ESTRESSE OXIDATIVO, ANTICONVULSIVANTES, FÁRMACOS (SISTEMA NERVOSO CENTRAL), RATOS, AORTA DE ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOURA, Kawane Fabricio et al. Vascular dysfunction programmed in male rats by topiramate during peripubertal period. Life Sciences, v. 343, p. 9 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.lfs.2024.122488. Acesso em: 01 jun. 2024.
APA
Moura, K. F., Silva, D. G. da, Vidigal, C. B., Silva, G. S. S. e, Pinto, I. C., Simão, A. N. C., et al. (2024). Vascular dysfunction programmed in male rats by topiramate during peripubertal period. Life Sciences, 343, 9 . doi:10.1016/j.lfs.2024.122488
NLM
Moura KF, Silva DG da, Vidigal CB, Silva GSS e, Pinto IC, Simão ANC, Marques BVD, Andrade FG de, Casagrande R, Gerardin DCC, Franco M do CP, Ceravolo GS, Akamine EH. Vascular dysfunction programmed in male rats by topiramate during peripubertal period [Internet]. Life Sciences. 2024 ; 343 9 .[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.lfs.2024.122488
Vancouver
Moura KF, Silva DG da, Vidigal CB, Silva GSS e, Pinto IC, Simão ANC, Marques BVD, Andrade FG de, Casagrande R, Gerardin DCC, Franco M do CP, Ceravolo GS, Akamine EH. Vascular dysfunction programmed in male rats by topiramate during peripubertal period [Internet]. Life Sciences. 2024 ; 343 9 .[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.lfs.2024.122488
Artigo de periodico
Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia (2023)
Lima, Keli Cristina de ; Carvalho, Maria Fernanda Lopes ; Martins, Diego Antonio Pereira ; Silva, Wellington Fernandes da; Nascimento, Mariane Cristina do ; Miranda, Lívia Bassani Lins De ; Medeiros, Rita de Cássia Cavaglieri ; Nardinelli, Luciana; Leal, Aline de Medeiros; Velloso, Elvira Deolinda Rodrigues Pereira ; Bendit, Israel ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: FM, ICB, FMRP
Subjects: HEMATOLOGIA, LEUCEMIA, LINFOMA, DOENÇAS SANGUÍNEAS E LINFÁTICAS, INIBIDORES QUÍMICOS, ESTUDOS DE COORTES, EXPRESSÃO GÊNICA, REAÇÃO EM CADEIA POR POLIMERASE, WESTERN BLOTTING, CITOMETRIA DE FLUXO, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. Blood, v. 142, p. 5886, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189786. Acesso em: 01 jun. 2024.
APA
Lima, K. C. de, Carvalho, M. F. L., Martins, D. A. P., Silva, W. F. da, Nascimento, M. C. do, Miranda, L. B. L. D., et al. (2023). Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia. Blood, 142, 5886. doi:10.1182/blood-2023-189786
NLM
Lima KC de, Carvalho MFL, Martins DAP, Silva WF da, Nascimento MC do, Miranda LBLD, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Schuringa JJ, Rego EM, Machado Neto JA. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. Blood. 2023 ; 142 5886.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1182/blood-2023-189786
Vancouver
Lima KC de, Carvalho MFL, Martins DAP, Silva WF da, Nascimento MC do, Miranda LBLD, Medeiros R de CC, Nardinelli L, Leal A de M, Velloso EDRP, Bendit I, Schuringa JJ, Rego EM, Machado Neto JA. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia [Internet]. Blood. 2023 ; 142 5886.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1182/blood-2023-189786
Artigo de periodico
Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia (2023)
Lima, Keli Cristina de ; Carvalho, Maria Fernanda Lopes ; Martins, Diego Antonio Pereira ; Nascimento, Mariane Cristina do ; Nogueira, Frederico Lisboa ; Medeiros, Rita de Cássia Cavaglieri ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, HEMATOLOGIA, LEUCEMIA MIELOIDE AGUDA, QUIMIOTERAPIA COMBINADA, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS, PROTEÍNAS, CÉLULAS MIELOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, v. 142, n. Supl. 1, p. 5774, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189998. Acesso em: 01 jun. 2024.
APA
Lima, K. C. de, Carvalho, M. F. L., Martins, D. A. P., Nascimento, M. C. do, Nogueira, F. L., Medeiros, R. de C. C., et al. (2023). Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia. Blood, 142( Supl. 1), 5774. doi:10.1182/blood-2023-189998
NLM
Lima KC de, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1182/blood-2023-189998
Vancouver
Lima KC de, Carvalho MFL, Martins DAP, Nascimento MC do, Nogueira FL, Medeiros R de CC, Schuringa JJ, Rego EM, Machado Neto JA. Identification of vulnerabilities for pharmacological inhibition of PIP4K2s in Acute Myeloid Leukemia [Internet]. Blood. 2023 ; 142( Supl. 1): 5774.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1182/blood-2023-189998
Artigo de periodico
Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models (2023)
Nascimento, Mariane Cristina do ; Martins, Diego Antonio Pereira ; Alcântara, Guilherme Augusto Sousa; Lima, Keli Cristina de ; Vicari, Hugo Passos ; Huls, Gerwin A. ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Ferreira, Marcelo José Pena ; Costa-Lotufo, Leticia Veras ; Machado Neto, João Agostinho
Source: Blood. Conference titles: 65th ASH Annual Meeting Abstracts. Unidades: IB, FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, HEMATOLOGIA, QUIMIOTERAPIA COMBINADA, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, NEOPLASIAS POR TIPO HISTOLÓGICO, APOPTOSE, DANO AO DNA, MITOCÔNDRIAS, PROTEÔMICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Mariane Cristina do et al. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, v. 142, n. res. 604, p. 5751, 2023Tradução . . Disponível em: https://doi.org/10.1182/blood-2023-189814. Acesso em: 01 jun. 2024.
APA
Nascimento, M. C. do, Martins, D. A. P., Alcântara, G. A. S., Lima, K. C. de, Vicari, H. P., Huls, G. A., et al. (2023). Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models. Blood, 142( res. 604), 5751. doi:10.1182/blood-2023-189814
NLM
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1182/blood-2023-189814
Vancouver
Nascimento MC do, Martins DAP, Alcântara GAS, Lima KC de, Vicari HP, Huls GA, Schuringa JJ, Rego EM, Ferreira MJP, Costa-Lotufo LV, Machado Neto JA. Cephalochromin-induced mitochondrial damage overcomes venetoclax-resistance in acute Myeloid Leukemia Models [Internet]. Blood. 2023 ; 142( res. 604): 5751.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1182/blood-2023-189814
Artigo de periodico
Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia (2023)
Lima, Keli Cristina de ; Carvalho, Maria Fernanda Lopes ; Pereira-Martins, Diego Antonio ; Nogueira, Frederico Lisboa ; Miranda, Lívia Bassani Lins de ; Mariane Cristina do Nascimento ; Cavaglieri, Rita de Cássia ; Schuringa, Jan Jacob ; Rego, Eduardo Magalhães ; Machado Neto, João Agostinho
Source: International Journal of Molecular Sciences. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, ANTINEOPLÁSICOS, APOPTOSE, PROTEÍNAS PROTO-ONCOGÊNICAS, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences, v. 24, n. 23, p. 12 , 2023Tradução . . Disponível em: https://doi.org/10.3390/ijms242316899. Acesso em: 01 jun. 2024.
APA
Lima, K. C. de, Carvalho, M. F. L., Pereira-Martins, D. A., Nogueira, F. L., Miranda, L. B. L. de, Mariane Cristina do Nascimento,, et al. (2023). Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia. International Journal of Molecular Sciences, 24( 23), 12 . doi:https://doi.org/10.3390/ijms242316899
NLM
Lima KC de, Carvalho MFL, Pereira-Martins DA, Nogueira FL, Miranda LBL de, Mariane Cristina do Nascimento, Cavaglieri R de C, Schuringa JJ, Rego EM, Machado Neto JA. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia [Internet]. International Journal of Molecular Sciences. 2023 ; 24( 23): 12 .[citado 2024 jun. 01 ] Available from: https://doi.org/10.3390/ijms242316899
Vancouver
Lima KC de, Carvalho MFL, Pereira-Martins DA, Nogueira FL, Miranda LBL de, Mariane Cristina do Nascimento, Cavaglieri R de C, Schuringa JJ, Rego EM, Machado Neto JA. Pharmacological inhibition of PIP4K2 potentiates venetoclax-induced apoptosis in Acute Myeloid Leukemia [Internet]. International Journal of Molecular Sciences. 2023 ; 24( 23): 12 .[citado 2024 jun. 01 ] Available from: https://doi.org/10.3390/ijms242316899
Artigo de periodico
Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia (2022)
Lima, Keli ; Pereira-Martins Diego A. ; Miranda, Lívia Bassani Lins de ; Coelho-Silva, Juan L. ; Leandro, Giovana da Silva ; Isabel Weinhäuser ; Cavaglieri, Rita de Cássia ; Silva, Wellington F.; Leal, Aline Medeiros; Lange, Ana Paula Alencar de Lima; Velloso, Elvira Deolinda Rodrigues Pereira ; Griessinger, Emmanuel ; Hilberink, Jacobien R. ; Huls, Gerwin A. ; Schuringa, Jan Jacob ; Rego, Eduardo M. ; Machado Neto, João Agostinho
Source: Blood. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, AMINOÁCIDOS, PROTEÍNAS QUINASES, DANO AO DNA, MITOCÔNDRIAS, HOMEOSTASE, LISOSSOMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli et al. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia. Blood, v. 140, p. 5965–5966, 2022Tradução . . Disponível em: https://doi.org/10.1182/blood-2022-165172. Acesso em: 01 jun. 2024.
APA
Lima, K., Pereira-Martins Diego A.,, Miranda, L. B. L. de, Coelho-Silva, J. L., Leandro, G. da S., Isabel Weinhäuser,, et al. (2022). Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia. Blood, 140, 5965–5966. doi:10.1182/blood-2022-165172
NLM
Lima K, Pereira-Martins Diego A., Miranda LBL de, Coelho-Silva JL, Leandro G da S, Isabel Weinhäuser, Cavaglieri R de C, Silva WF, Leal AM, Lange APA de L, Velloso EDRP, Griessinger E, Hilberink JR, Huls GA, Schuringa JJ, Rego EM, Machado Neto JA. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia [Internet]. Blood. 2022 ; 140 5965–5966.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1182/blood-2022-165172
Vancouver
Lima K, Pereira-Martins Diego A., Miranda LBL de, Coelho-Silva JL, Leandro G da S, Isabel Weinhäuser, Cavaglieri R de C, Silva WF, Leal AM, Lange APA de L, Velloso EDRP, Griessinger E, Hilberink JR, Huls GA, Schuringa JJ, Rego EM, Machado Neto JA. Targeting PIP4K2 lipid kinases through Thz-P1-2 reveals vulnerabilities related to mitochondrial homeostasis and autophagy in acute leukemia [Internet]. Blood. 2022 ; 140 5965–5966.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1182/blood-2022-165172
Artigo de periodico
NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells (2022)
Silva, Jean Carlos Lipreri da ; Carvalho, Maria Fernanda Lopes; Miranda, Lívia Bassani Lins De ; Almeida, Bruna Oliveira de ; Lima, Keli Cristina de; Machado Neto, João Agostinho
Source: Investigational New Drugs. Unidade: ICB
Subjects: FARMACOLOGIA, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS PANCREÁTICAS, COMPOSTOS AROMÁTICOS, CITOESQUELETO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Investigational New Drugs, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10637-022-01249-z. Acesso em: 01 jun. 2024.
APA
Silva, J. C. L. da, Carvalho, M. F. L., Miranda, L. B. L. D., Almeida, B. O. de, Lima, K. C. de, & Machado Neto, J. A. (2022). NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells. Investigational New Drugs, 1-10. doi:10.1007/s10637-022-01249-z
NLM
Silva JCL da, Carvalho MFL, Miranda LBLD, Almeida BO de, Lima KC de, Machado Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells [Internet]. Investigational New Drugs. 2022 ; 1-10.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s10637-022-01249-z
Vancouver
Silva JCL da, Carvalho MFL, Miranda LBLD, Almeida BO de, Lima KC de, Machado Neto JA. NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells [Internet]. Investigational New Drugs. 2022 ; 1-10.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s10637-022-01249-z
Artigo de periodico
NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells (2022)
Miranda, Lívia Bassani Lins De ; Lima, Keli Cristina de ; Silva, Juan Luiz Coelho ; Traina, Fabiola ; Kobayashi, Susumu S. ; Machado Neto, João Agostinho
Source: Scientific Reports. Unidades: FMRP, ICB, FM
Subjects: FARMACOLOGIA, NEOPLASIAS PULMONARES, ANTINEOPLÁSICOS, NEOPLASIAS PULMONARES, ANTINEOPLÁSICOS, CÉLULAS CULTIVADAS DE TUMOR, ONCOGENES, TRANSDUÇÃO DE SINAL CELULAR, PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Lívia Bassani Lins De et al. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-21419-6. Acesso em: 01 jun. 2024.
APA
Miranda, L. B. L. D., Lima, K. C. de, Silva, J. L. C., Traina, F., Kobayashi, S. S., & Machado Neto, J. A. (2022). NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Scientific Reports, 12, 1-11. doi:10.1038/s41598-022-21419-6
NLM
Miranda LBLD, Lima KC de, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1038/s41598-022-21419-6
Vancouver
Miranda LBLD, Lima KC de, Silva JLC, Traina F, Kobayashi SS, Machado Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells [Internet]. Scientific Reports. 2022 ; 12 1-11.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1038/s41598-022-21419-6
Artigo de periodico
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy (2022)
Lima, Keli Cristina de ; Martins, Diego Antonio Pereira ; Miranda, Lívia Bassani Lins De ; Silva, Juan Luiz Coelho ; Leandro, Giovana da Silva ; Weinhäuser, Isabel ; Cavaglieri, Rita de Cássia; Leal, Aline de Medeiros; Silva, Wellington Fernandes da; Lange, Ana Paula Alencar de Lima; Velloso, Elvira Deolinda Rodrigues Pereira ; Rego, Eduardo Magalhães ; Griessinger, Emmanuel ; Hilberink, Jacobien R. ; Ammatuna, Emanuele ; Huls, Gerwin ; Schuringa, Jan Jacob ; Machado Neto, João Agostinho
Source: Blood Cancer Journal. Unidades: FM, ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, HOMEOSTASE, APOPTOSE, MITOCÔNDRIAS, ESPECTROMETRIA DE MASSAS, CROMATOGRAFIA LÍQUIDA, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, v. 12, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41408-022-00747-w. Acesso em: 01 jun. 2024.
APA
Lima, K. C. de, Martins, D. A. P., Miranda, L. B. L. D., Silva, J. L. C., Leandro, G. da S., Weinhäuser, I., et al. (2022). The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy. Blood Cancer Journal, 12, 1-11. doi:10.1038/s41408-022-00747-w
NLM
Lima KC de, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1038/s41408-022-00747-w
Vancouver
Lima KC de, Martins DAP, Miranda LBLD, Silva JLC, Leandro G da S, Weinhäuser I, Cavaglieri R de C, Leal A de M, Silva WF da, Lange APA de L, Velloso EDRP, Rego EM, Griessinger E, Hilberink JR, Ammatuna E, Huls G, Schuringa JJ, Machado Neto JA. The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy [Internet]. Blood Cancer Journal. 2022 ; 12 1-11.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1038/s41408-022-00747-w
Artigo de periodico
Vasorelaxant activity of AP39, a mitochondria-targeted H2S donor, on mouse mesenteric artery rings in vitro (2022)
Marques, Leonardo André da Costa ; Teixeira, Simone Aparecida ; Jesus, Flávia Neto de ; Wood, Mark E. ; Torregrossa, Roberta ; Whiteman, Matthew; Costa, Soraia Katia Pereira ; Muscará, Marcelo Nicolás (Orientador)
Source: Biomolecules. Unidade: ICB
Subjects: FARMACOLOGIA, MITOCÔNDRIAS, ÁCIDO SULFÚRICO, VASODILATAÇÃO, VASOS CORONÁRIOS, FÁRMACOS (SISTEMA CARDIOVASCULAR), CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, REAÇÃO EM CADEIA POR POLIMERASE, WESTERN BLOTTING, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARQUES, Leonardo André da Costa et al. Vasorelaxant activity of AP39, a mitochondria-targeted H2S donor, on mouse mesenteric artery rings in vitro. Biomolecules, v. 12, n. 2, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12020280. Acesso em: 01 jun. 2024.
APA
Marques, L. A. da C., Teixeira, S. A., Jesus, F. N. de, Wood, M. E., Torregrossa, R., Whiteman, M., & Costa, S. K. P. (2022). Vasorelaxant activity of AP39, a mitochondria-targeted H2S donor, on mouse mesenteric artery rings in vitro. Biomolecules, 12( 2), 1-14. doi:10.3390/biom12020280
NLM
Marques LA da C, Teixeira SA, Jesus FN de, Wood ME, Torregrossa R, Whiteman M, Costa SKP. Vasorelaxant activity of AP39, a mitochondria-targeted H2S donor, on mouse mesenteric artery rings in vitro [Internet]. Biomolecules. 2022 ; 12( 2): 1-14.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3390/biom12020280
Vancouver
Marques LA da C, Teixeira SA, Jesus FN de, Wood ME, Torregrossa R, Whiteman M, Costa SKP. Vasorelaxant activity of AP39, a mitochondria-targeted H2S donor, on mouse mesenteric artery rings in vitro [Internet]. Biomolecules. 2022 ; 12( 2): 1-14.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3390/biom12020280
Artigo de periodico
Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms (2022)
Vicari, Hugo Passos ; Lima, Keli Cristina de ; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho
Source: Cancers. Unidades: ICB, FM
Subjects: FARMACOLOGIA, LEUCEMIA, ANTINEOPLÁSICOS, MICROTÚBULOS, LEUCÓCITOS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICARI, Hugo Passos et al. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, v. 14, n. 24, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14246080. Acesso em: 01 jun. 2024.
APA
Vicari, H. P., Lima, K. C. de, Lotufo, L. V. C., & Machado Neto, J. A. (2022). Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, 14( 24), 1-15. doi:10.3390/cancers14246080
NLM
Vicari HP, Lima KC de, Lotufo LVC, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3390/cancers14246080
Vancouver
Vicari HP, Lima KC de, Lotufo LVC, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3390/cancers14246080
Artigo de periodico
Myrtenol reduces orofacial nociception and inflammation in mice through p38-MAPK and Cytokine inhibition (2022)
Oliveira, Janaíne Prata de ; Abreu, Fabíula F. ; Bispo, José Marcos M. ; Cerqueira, Anderson Romério Azevedo ; Santos, José Ronaldo dos ; Correa, Cristiane B. ; Costa, Soraia Katia Pereira ; Camargo, Enilton A.
Source: Frontiers in Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, CITOCINAS, DOR FACIAL, PROTEÍNAS QUINASES, ANSIOLÍTICOS, FÁRMACOS (SISTEMA NERVOSO CENTRAL)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Janaíne Prata de et al. Myrtenol reduces orofacial nociception and inflammation in mice through p38-MAPK and Cytokine inhibition. Frontiers in Pharmacology, v. 13, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.910219. Acesso em: 01 jun. 2024.
APA
Oliveira, J. P. de, Abreu, F. F., Bispo, J. M. M., Cerqueira, A. R. A., Santos, J. R. dos, Correa, C. B., et al. (2022). Myrtenol reduces orofacial nociception and inflammation in mice through p38-MAPK and Cytokine inhibition. Frontiers in Pharmacology, 13, 1-8. doi:10.3389/fphar.2022.910219
NLM
Oliveira JP de, Abreu FF, Bispo JMM, Cerqueira ARA, Santos JR dos, Correa CB, Costa SKP, Camargo EA. Myrtenol reduces orofacial nociception and inflammation in mice through p38-MAPK and Cytokine inhibition [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-8.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3389/fphar.2022.910219
Vancouver
Oliveira JP de, Abreu FF, Bispo JMM, Cerqueira ARA, Santos JR dos, Correa CB, Costa SKP, Camargo EA. Myrtenol reduces orofacial nociception and inflammation in mice through p38-MAPK and Cytokine inhibition [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-8.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3389/fphar.2022.910219
Artigo de periodico
Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia (2021)
Silva, Jean Carlos Lipreri da ; Silva, Juan Luiz Coelho ; Lima, Keli ; Vicari, Hugo Passos ; Lazarini, Mariana ; Lotufo, Leticia Veras Costa ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: Cellular Oncology. Unidades: ICB, FMRP
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, ANTINEOPLÁSICOS, CITOESQUELETO, EXPRESSÃO GÊNICA, GENÔMICA, TRANSDUÇÃO DE SINAL CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jean Carlos Lipreri da et al. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cellular Oncology, v. 44, n. 5, p. 1105-1117, 2021Tradução . . Disponível em: https://doi.org/10.1007/s13402-021-00621-0. Acesso em: 01 jun. 2024.
APA
Silva, J. C. L. da, Silva, J. L. C., Lima, K., Vicari, H. P., Lazarini, M., Lotufo, L. V. C., et al. (2021). Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia. Cellular Oncology, 44( 5), 1105-1117. doi:10.1007/s13402-021-00621-0
NLM
Silva JCL da, Silva JLC, Lima K, Vicari HP, Lazarini M, Lotufo LVC, Traina F, Machado Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia [Internet]. Cellular Oncology. 2021 ; 44( 5): 1105-1117.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s13402-021-00621-0
Vancouver
Silva JCL da, Silva JLC, Lima K, Vicari HP, Lazarini M, Lotufo LVC, Traina F, Machado Neto JA. Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia [Internet]. Cellular Oncology. 2021 ; 44( 5): 1105-1117.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s13402-021-00621-0
Artigo de periodico
Targeting glioma cells by antineoplastic activity of reversine (2021)
Hirakata, Camila Yumi Soares ; Lima, Keli ; Almeida, Bruna Oliveira De ; Miranda, Lívia Bassani Lins De ; Florêncio, Katharine Gurgel Dias ; Furtado, Luciana Costa ; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho
Source: Oncology Letters. Unidade: ICB
Subjects: FARMACOLOGIA, APOPTOSE, PROTEÍNAS QUINASES, GLIOMA, NEOPLASIAS CEREBRAIS, CÉLULAS CULTIVADAS DE TUMOR, ANTINEOPLÁSICOS, REAÇÃO EM CADEIA POR POLIMERASE, WESTERN BLOTTING
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRAKATA, Camila Yumi Soares et al. Targeting glioma cells by antineoplastic activity of reversine. Oncology Letters, v. 22, n. 2, p. 1-9, 2021Tradução . . Disponível em: https://doi.org/10.3892/ol.2021.12871. Acesso em: 01 jun. 2024.
APA
Hirakata, C. Y. S., Lima, K., Almeida, B. O. D., Miranda, L. B. L. D., Florêncio, K. G. D., Furtado, L. C., et al. (2021). Targeting glioma cells by antineoplastic activity of reversine. Oncology Letters, 22( 2), 1-9. doi:10.3892/ol.2021.12871
NLM
Hirakata CYS, Lima K, Almeida BOD, Miranda LBLD, Florêncio KGD, Furtado LC, Lotufo LVC, Machado Neto JA. Targeting glioma cells by antineoplastic activity of reversine [Internet]. Oncology Letters. 2021 ; 22( 2): 1-9.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3892/ol.2021.12871
Vancouver
Hirakata CYS, Lima K, Almeida BOD, Miranda LBLD, Florêncio KGD, Furtado LC, Lotufo LVC, Machado Neto JA. Targeting glioma cells by antineoplastic activity of reversine [Internet]. Oncology Letters. 2021 ; 22( 2): 1-9.[citado 2024 jun. 01 ] Available from: https://doi.org/10.3892/ol.2021.12871
Artigo de periodico
AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis (2021)
Carlos, Jorge Antonio Elias Godoy; Lima, Kely; Lotufo, Leticia Veras Costa ; Leitão, Andrei ; Machado Neto, João Agostinho
Source: Investigational New Drugs. Unidades: ICB, IQSC
Subjects: FARMACOLOGIA, LEUCEMIA, ANTINEOPLÁSICOS, FOSFOPROTEÍNAS, MICROTÚBULOS, CÉLULAS CULTIVADAS DE TUMOR, PROLIFERAÇÃO CELULAR, CITOESQUELETO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Jorge Antonio Elias Godoy et al. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis. Investigational New Drugs, v. 39, n. 4, p. 1139-1149, 2021Tradução . . Disponível em: https://doi.org/10.1007/s10637-021-01066-w. Acesso em: 01 jun. 2024.
APA
Carlos, J. A. E. G., Lima, K., Lotufo, L. V. C., Leitão, A., & Machado Neto, J. A. (2021). AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis. Investigational New Drugs, 39( 4), 1139-1149. doi:10.1007/s10637-021-01066-w
NLM
Carlos JAEG, Lima K, Lotufo LVC, Leitão A, Machado Neto JA. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis [Internet]. Investigational New Drugs. 2021 ; 39( 4): 1139-1149.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s10637-021-01066-w
Vancouver
Carlos JAEG, Lima K, Lotufo LVC, Leitão A, Machado Neto JA. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis [Internet]. Investigational New Drugs. 2021 ; 39( 4): 1139-1149.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s10637-021-01066-w
Artigo de periodico
Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter? (2020)
Apolinário, Alexsandra Conceição ; Hauschke, Leon; Nunes, Jessica Ribeiro; Lopes, Luciana Biagini
Source: Journal of Drug Delivery Science and Technology. Unidade: ICB
Subjects: FARMACOLOGIA, NANOPARTÍCULAS, FÁRMACOS, MEDICAMENTO, FOSFOLIPÍDEOS, ETANOL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter?. Journal of Drug Delivery Science and Technology, v. 60, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jddst.2020.102045. Acesso em: 01 jun. 2024.
APA
Apolinário, A. C., Hauschke, L., Nunes, J. R., & Lopes, L. B. (2020). Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter? Journal of Drug Delivery Science and Technology, 60. doi:10.1016/j.jddst.2020.102045
NLM
Apolinário AC, Hauschke L, Nunes JR, Lopes LB. Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter? [Internet]. Journal of Drug Delivery Science and Technology. 2020 ; 60[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.jddst.2020.102045
Vancouver
Apolinário AC, Hauschke L, Nunes JR, Lopes LB. Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter? [Internet]. Journal of Drug Delivery Science and Technology. 2020 ; 60[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.jddst.2020.102045
Artigo de periodico
Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia (2020)
Carlos, Jorge Antonio Elias Godoy; Lima, Keli ; Silva, Juan Luiz Coelho da ; Paiva, Raquel de Melo Alves ; Moreno, Natália Cestari ; Vicari, Hugo Passos ; Santos, Fábio Pires de Souza ; Hamerschlak, Nelson ; Traina, Fabiola ; Lotufo, Leticia Veras Costa ; Machado Neto, João Agostinho
Source: Cellular Oncology (Dordrecht, 2011). Unidades: FMRP, ICB, IQ, FM
Subjects: FARMACOLOGIA, APOPTOSE, LEUCEMIA MIELOIDE AGUDA, MITOSE, NEOPLASIAS, PURINAS, EXPRESSÃO GÊNICA, LINFÓCITOS, PROLIFERAÇÃO CELULAR, DANO AO DNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARLOS, Jorge Antonio Elias Godoy et al. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia. Cellular Oncology (Dordrecht, 2011), v. 43, n. 6, p. 1191-1201, 2020Tradução . . Disponível em: https://doi.org/10.1007/s13402-020-00551-3. Acesso em: 01 jun. 2024.
APA
Carlos, J. A. E. G., Lima, K., Silva, J. L. C. da, Paiva, R. de M. A., Moreno, N. C., Vicari, H. P., et al. (2020). Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia. Cellular Oncology (Dordrecht, 2011), 43( 6), 1191-1201. doi:10.1007/s13402-020-00551-3
NLM
Carlos JAEG, Lima K, Silva JLC da, Paiva R de MA, Moreno NC, Vicari HP, Santos FP de S, Hamerschlak N, Traina F, Lotufo LVC, Machado Neto JA. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia [Internet]. Cellular Oncology (Dordrecht, 2011). 2020 ; 43( 6): 1191-1201.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s13402-020-00551-3
Vancouver
Carlos JAEG, Lima K, Silva JLC da, Paiva R de MA, Moreno NC, Vicari HP, Santos FP de S, Hamerschlak N, Traina F, Lotufo LVC, Machado Neto JA. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia [Internet]. Cellular Oncology (Dordrecht, 2011). 2020 ; 43( 6): 1191-1201.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1007/s13402-020-00551-3
Artigo de periodico
Activity-dependent neuronal Klotho enhances astrocytic aerobic glycolysis (2019)
Mazucanti, Caio Henrique ; Kawamoto, Elisa Mitiko ; Mattson, Mark P.; Camandola, Simonetta ; Scavone, Cristoforo
Source: Journal of Cerebral Blood Flow and Metabolism. Unidade: ICB
Subjects: SISTEMA NERVOSO CENTRAL, ASTRÓCITOS, ENVELHECIMENTO, METABOLISMO ENERGÉTICO, LACTATOS, HIPOCAMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAZUCANTI, Caio Henrique et al. Activity-dependent neuronal Klotho enhances astrocytic aerobic glycolysis. Journal of Cerebral Blood Flow and Metabolism, v. 39, n. 8, p. 1544-1556, 2019Tradução . . Disponível em: https://doi.org/10.1177/0271678X18762700. Acesso em: 01 jun. 2024.
APA
Mazucanti, C. H., Kawamoto, E. M., Mattson, M. P., Camandola, S., & Scavone, C. (2019). Activity-dependent neuronal Klotho enhances astrocytic aerobic glycolysis. Journal of Cerebral Blood Flow and Metabolism, 39( 8), 1544-1556. doi:10.1177/0271678X18762700
NLM
Mazucanti CH, Kawamoto EM, Mattson MP, Camandola S, Scavone C. Activity-dependent neuronal Klotho enhances astrocytic aerobic glycolysis [Internet]. Journal of Cerebral Blood Flow and Metabolism. 2019 ; 39( 8): 1544-1556.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1177/0271678X18762700
Vancouver
Mazucanti CH, Kawamoto EM, Mattson MP, Camandola S, Scavone C. Activity-dependent neuronal Klotho enhances astrocytic aerobic glycolysis [Internet]. Journal of Cerebral Blood Flow and Metabolism. 2019 ; 39( 8): 1544-1556.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1177/0271678X18762700
Artigo de periodico
Walker 256 tumor growth suppression by crotoxin involves formyl peptide receptors and lipoxin A4 (2016)
Brigatte, Patrícia ; Faiad, Odair Jorge ; Nocelli, Roberta Cornélio Ferreira; Landgraf, Richardt Gama ; Palma, Mario Sérgio; Cury, Yara ; Curi, Rui ; Vessoni, Sandra Coccuzzo Sampaio
Source: Mediators of Inflammation. Unidade: ICB
Subjects: FISIOLOGIA, TUMOR DE WALKER ANIMAL, SERPENTES, LIPOXIGENASE, TOXINAS EM ANIMAL, ATIVAÇÃO ENZIMÁTICA, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRIGATTE, Patrícia et al. Walker 256 tumor growth suppression by crotoxin involves formyl peptide receptors and lipoxin A4. Mediators of Inflammation, v. 2016, 2016Tradução . . Disponível em: https://doi.org/10.1155/2016/2457532. Acesso em: 01 jun. 2024.
APA
Brigatte, P., Faiad, O. J., Nocelli, R. C. F., Landgraf, R. G., Palma, M. S., Cury, Y., et al. (2016). Walker 256 tumor growth suppression by crotoxin involves formyl peptide receptors and lipoxin A4. Mediators of Inflammation, 2016. doi:10.1155/2016/2457532
NLM
Brigatte P, Faiad OJ, Nocelli RCF, Landgraf RG, Palma MS, Cury Y, Curi R, Vessoni SCS. Walker 256 tumor growth suppression by crotoxin involves formyl peptide receptors and lipoxin A4 [Internet]. Mediators of Inflammation. 2016 ; 2016[citado 2024 jun. 01 ] Available from: https://doi.org/10.1155/2016/2457532
Vancouver
Brigatte P, Faiad OJ, Nocelli RCF, Landgraf RG, Palma MS, Cury Y, Curi R, Vessoni SCS. Walker 256 tumor growth suppression by crotoxin involves formyl peptide receptors and lipoxin A4 [Internet]. Mediators of Inflammation. 2016 ; 2016[citado 2024 jun. 01 ] Available from: https://doi.org/10.1155/2016/2457532

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration